Orphan designation: Ivosidenib Treatment of chondrosarcoma, 10/11/2024 Positive
Orphan designation: Ivosidenib Treatment of chondrosarcoma, 10/11/2024 Positive
Orphan designation: Ivosidenib Treatment of chondrosarcoma, 10/11/2024 Positive
Minutes of the COMP meeting 08-10 October 2024
Draft concept paper on the European Platform for Regulatory Science Research
Draft Regulatory Science Research Needs - 2024 update
Shortage of Ixiaro (Japanese encephalitis vaccine (inactivated, adsorbed))
Orphan designation: Atacicept Treatment of primary IgA nephropathy, 10/11/2024 Positive
Orphan designation: 3-(5-(2-Hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile Treatment of X-linked spinal and bulbar muscular atrophy (Kennedy's disease), 10/11/2024 Positive
Orphan designation: 4,9-Dimethyl-6-(4'-aminophenyl)-2H-furo[2,3-h]-1-benzopyran-2-one Treatment of cystic fibrosis, 10/11/2024 Positive
Orphan designation: Interleukin-12, human, recombinant Treatment of cutaneous T-cell lymphoma, 10/11/2024 Positive
Social Media Data for Real World Evidence in Regulatory Decision Making